DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| Excelin Home Health, LLC Healthcare services | unattributed | 2 | at least $1.8M | 29c | n/a | Oct 1, 2026 | Dec 31, 2021 |
| US-GAAP Investment Healthcare services | unattributed | 3 | at least $1.7M | 34c | n/a | Jul 31, 2026 | Dec 31, 2024 |
| UVP Management, LLC Healthcare services | unattributed | 3 | at least $1.7M | 99c | n/a | Sep 30, 2027 | Sep 30, 2023 |
| K•• P••••• R••• Healthcare services | unattributed | 1 | at least $1.7M | 67c | n/a | Jun 28, 2028 | Dec 31, 2024 |
| B••• C•••• Life sciences | unattributed | 1 | at least $1.7M | 100c | n/a | Jan 21, 2031 | Dec 31, 2022 |
| O•• W•••••• M••••• S••• I•• Life sciences | unattributed | 1 | at least $1.6M | 99c | n/a | Sep 3, 2030 | Sep 30, 2025 |
| B••••• B••••••••• S•••••• S••••••• L•• T•••• A•••••••• Healthcare services | unattributed | 1 | at least $1.6M | 100c | n/a | Jun 21, 2029 | Jun 30, 2026 |
| N•••••• Life sciences · grade B | unattributed | 1 | at least $1.6M | 100c | n/a | Dec 31, 2028 | Dec 31, 2023 |
| M•••• W••• A•••••••• S••••••• I•• Healthcare services | unattributed | 1 | at least $1.5M | 100c | n/a | Mar 31, 2028 | Mar 31, 2026 |
| A••••••••• C••• N•• A•• B•••• L•• Healthcare services | unattributed | 1 | at least $1.5M | 100c | n/a | Jun 29, 2031 | Jun 30, 2026 |
| C••••• M•••••• Life sciences | Sponsor not establishedpossible: S••••••••• C•••••• L• (a company of this name is on the sponsor's portfolio page) | 1 | at least $1.5M | 101c | n/a | Oct 31, 2028 | Jun 30, 2023 |
| M•••••• Life sciences · grade B | unattributed | 1 | at least $1.5M | 100c | n/a | May 10, 2028 | Dec 31, 2022 |
| M•••••• D••••• I••• S••••• A•••••••• Life sciences | unattributed | 1 | at least $1.4M | 100c | n/a | Jul 11, 2029 | Jun 30, 2025 |
| R•••••• I•• Life sciences | unattributed | 5 | at least $1.4M | 100c | n/a | Apr 18, 2031 | Dec 31, 2021 |
| S••••• Life sciences · grade B | unattributed | 1 | at least $1.4M | 66c | n/a | Dec 22, 2027 | Dec 31, 2022 |
| I•••••••• H•••••• I•• Healthcare services | unattributed | 5 | at least $1.4M | 35c | n/a | May 27, 2032 | Dec 31, 2022 |
| M•••••• D••••• I••• T•••• A•••••••• Life sciences | unattributed | 1 | at least $1.3M | 100c | n/a | Jul 11, 2029 | Dec 31, 2025 |
| D••••• C••• A••••••• D•• I••••••••• H•••••• L•• Healthcare services | unattributed | 1 | at least $1.3M | 90c | n/a | Jun 2, 2031 | Dec 31, 2022 |
| H••••••••• Life sciences | Sponsor not establishedpossible: R•••••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $1.1M | 100c | n/a | Aug 20, 2029 | Mar 31, 2023 |
| M•• H••••••••• H•••••••• L•• Life sciences | unattributed | 5 | at least $1.0M | 95c | n/a | Jan 28, 2029 | Dec 31, 2022 |
| U• A•••• C••• S•••••••• L•• • C•••••••• Healthcare services · Life sciences | unattributed | 1 | at least $1.0M | 96c | n/a | May 15, 2029 | Dec 31, 2025 |
| C••••••• p•• Life sciences | unattributed | 1 | at least $951,000 | 101c | n/a | Jun 3, 2033 | Dec 31, 2024 |
| W•••••• D••••• S•••••••• I•• Healthcare services | unattributed | 2 | at least $942,000 | 107c | n/a | Jan 28, 2032 | Dec 31, 2021 |
| P•••••• H••••• H•••••• C•••• A•••••••• N•• 1• Healthcare services | unattributed | 1 | at least $877,000 | 100c | n/a | Nov 8, 2032 | Dec 31, 2025 |
| G•••••• I••••••••• S••••••• D••••••••• A••••••• C•••••• Life sciences | unattributed | 2 | at least $720,000 | 101c | n/a | Apr 14, 2033 | Jun 30, 2026 |
| B••••• U• B•••• L•• U•• Life sciences | unattributed | 1 | at least $696,000 | 100c | n/a | Sep 30, 2030 | Sep 30, 2025 |
| T••••••• Life sciences | unattributed | 2 | at least $689,655 | 113c | n/a | Jun 23, 2032 | Dec 31, 2025 |
| D••••••• H•••••• L•• Healthcare services · Life sciences | unattributed | 1 | at least $675,000 | 103c | n/a | Nov 26, 2030 | Jun 30, 2026 |
| R•• • M•••••• Life sciences | unattributed | 1 | at least $660,089 | 97c | n/a | Feb 4, 2028 | Dec 31, 2022 |
| C••••••• Life sciences | unattributed | 2 | at least $622,939 | 101c | n/a | Aug 30, 2030 | Mar 31, 2022 |
| V•••• Life sciences · grade B | unattributed | 1 | at least $546,820 | 95c | n/a | Oct 29, 2031 | Dec 31, 2024 |
| B••••• O••• S••••••••• M••••••••• L•• E••••• A•••••••• Healthcare services | unattributed | 1 | at least $502,000 | 100c | n/a | Dec 14, 2026 | Sep 30, 2025 |
| E••••••• H••••• P••••••• H•••••••• L•• Healthcare services | Sponsor not establishedpossible: W•••••• P••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $500,000 | 100c | n/a | Feb 9, 2033 | Jun 30, 2026 |
| N••••••• T••••••••• Life sciences | unattributed | 1 | at least $473,000 | 100c | n/a | Jun 1, 2027 | Dec 31, 2022 |
| H••••••••• L•••• S•••••• G•••• Life sciences | unattributed | 1 | at least $446,195 | 100c | n/a | Feb 2, 2033 | Mar 31, 2026 |
| A•••• S••••••••• L•• Life sciences | unattributed | 2 | at least $415,000 | 100c | n/a | Jan 31, 2028 | Mar 31, 2024 |
| K• C•••••• A••••••••• C•••••• S•••• A•••••••• Life sciences | unattributed | 1 | at least $383,000 | 100c | n/a | Dec 30, 2026 | Dec 31, 2024 |
| E•• M••• L•• Healthcare services | unattributed | 2 | at least $351,000 | 100c | n/a | Dec 31, 2028 | Mar 31, 2024 |
| E••••••• H••••• C• Healthcare services | unattributed | 1 | at least $350,000 | 88c | n/a | Nov 10, 2031 | Mar 31, 2024 |
| C•••••••• M•••••• A••••••••• C••• Healthcare services | unattributed | 2 | at least $342,000 | 102c | n/a | Dec 15, 2028 | Mar 31, 2024 |
| O••• O••••••••• M••••••••• C••••••••• L•• Life sciences | unattributed | 1 | at least $301,000 | 70c | n/a | Feb 28, 2027 | Dec 31, 2022 |
| P••••••• P••••• L•• • C•••••••• Healthcare services · Life sciences | unattributed | 1 | at least $300,000 | 101c | n/a | Apr 17, 2032 | Mar 31, 2026 |
| E•••• B••••••• I•• Life sciences | unattributed | 2 | at least $254,000 | 99c | n/a | Jul 7, 2028 | Mar 31, 2022 |
| I•••• I•• Life sciences | unattributed | 4 | at least $244,000 | 100c | n/a | Jan 2, 2031 | Dec 31, 2023 |
| C•••••• I•••••• A••••••••• C•••• F•••• A•••••••• Healthcare services | unattributed | 1 | at least $228,000 | 100c | n/a | Jan 3, 2030 | Jun 30, 2026 |
| H••• •••••• A••••••• A•••••• H••••••• Healthcare services | unattributed | 1 | at least $209,000 | 105c | n/a | Jun 30, 2027 | Mar 31, 2026 |
| O••••• H•••••••• L•• Healthcare services · grade B | unattributed | 1 | at least $196,000 | 98c | n/a | Dec 28, 2027 | Dec 31, 2024 |
| B••••• U• B•••• L•• T•••••• B•• D•••••• Life sciences | unattributed | 1 | at least $167,000 | 101c | n/a | Sep 30, 2030 | Dec 31, 2024 |
| B•••• 2• M•••• H••••••• L•• Healthcare services · grade B | unattributed | 1 | at least $160,000 | 100c | n/a | Jun 30, 2032 | Jun 30, 2025 |
| A••••••• P•• Life sciences | unattributed | 1 | at least $130,000 | 101c | n/a | Jan 28, 2031 | Mar 31, 2026 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.